publicações selecionadas
-
artigo de revista
- Long-term coexistence of Pseudomonas aeruginosa and Staphylococcus aureus using an in vitro cystic fibrosis model. Antibiotics. 2021
- Fostering Innovation in the Treatment of Chronic Polymicrobial Cystic Fibrosis-Associated Infections Exploring Aspartic Acid and Succinic Acid as Ciprofloxacin Adjuvants. Frontiers in Cellular and Infection Microbiology. 2020
- Unveiling the early events of Pseudomonas aeruginosa adaptation in cystic fibrosis airway environment using a long-term in vitro maintenance. International Journal of Medical Microbiology. 2018
-
documento
- Inhaled mucus-penetrating lipid/polymer nanoparticles for extended antibiotic delivery in cystic fibrosis airways 2024
- On the Path to Boost Ciprofloxacin Action Against Pseudomonas aeruginosa Biofilm-Associated Infections in Cystic Fibrosis Environment: Exploring Mucus-Penetrating Nanoparticles 2023
- Prevenção de infeções crónicas de Pseudomonas aeruginosa em fibrose quística: o ácido aspártico como terapia adjuvante de tobramicina 2022
- Exploring glutathione as an adjuvante of anti-biofilm strategies against Pseudomonas aeruginosa 2018
- Deciphering the role of Staphylococcus aureus in Pseudomonas aeruginosa adaptation to cystic fibrosis lungs: bystander or intervener? 2017
-
teses